Geneva, 9 May 2019 – The Medicines Patent Pool (MPP) has provided feedback on the World Health Organization’s (WHO) draft Global Strategy for TB Research and Innovation. The foundation welcomes the fact that the Global Strategy acknowledges the critical importance of ensuring that people with tuberculosis (TB) can benefit from advancements in TB research and the need for new models of innovation that are not only needs driven and evidence based, but guided by the core principles of affordability, efficiency, equity, sustainability and collaboration.

Patent pooling is recognised in the strategy as one possible approach to supporting the development of needed medicines in the context of an enabling environment for TB research and innovation. The MPP is the first patent pool in the field of health and as such welcomes the opportunity to offer its perspective on the potential of the approach in the field of TB.

Read the MPP’s feedback in full HERE

More information on the WHO call for contribution to the public consultation on the development of a Global Strategy for TB Research and Innovation HERE